Anika Therapeutics Shares Outstanding 2006-2021 | ANIK

Anika Therapeutics shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Anika Therapeutics Annual Shares Outstanding
(Millions of Shares)
2020 14
2019 14
2018 15
2017 15
2016 15
2015 15
2014 15
2013 15
2012 14
2011 14
2010 14
2009 12
2008 11
2007 11
2006 11
2005 11
Anika Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 15
2021-03-31 14
2020-12-31 14
2020-09-30 14
2020-06-30 14
2020-03-31 14
2019-12-31 14
2019-09-30 14
2019-06-30 14
2019-03-31 14
2018-12-31 15
2018-09-30 14
2018-06-30 15
2018-03-31 15
2017-12-31 15
2017-09-30 15
2017-06-30 15
2017-03-31 15
2016-12-31 15
2016-09-30 15
2016-06-30 15
2016-03-31 15
2015-12-31 15
2015-09-30 15
2015-06-30 15
2015-03-31 15
2014-12-31 15
2014-09-30 15
2014-06-30 15
2014-03-31 15
2013-12-31 15
2013-09-30 15
2013-06-30 15
2013-03-31 14
2012-12-31 14
2012-09-30 14
2012-06-30 14
2012-03-31 14
2011-12-31 14
2011-09-30 14
2011-06-30 14
2011-03-31 14
2010-12-31 14
2010-09-30 14
2010-06-30 14
2010-03-31 14
2009-12-31 12
2009-09-30 12
2009-06-30 12
2009-03-31 11
2008-12-31 11
2008-09-30 11
2008-06-30 12
2008-03-31 12
2007-12-31 11
2007-09-30 12
2007-06-30 11
2007-03-31 11
2006-12-31 11
2006-09-30 11
2006-06-30 11
2006-03-31 11
2005-12-31 11
2005-09-30 11
2005-06-30 12
2005-03-31 11
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.564B $0.130B
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $170.876B 52.78
Bristol Myers Squibb (BMY) United States $134.438B 8.95
Amgen (AMGN) United States $122.151B 13.23
CSL (CSLLY) Australia $100.620B 0.00
Gilead Sciences (GILD) United States $88.970B 8.60
BioNTech SE (BNTX) Germany $82.216B 17.74
Regeneron Pharmaceuticals (REGN) United States $68.547B 11.77
Illumina (ILMN) United States $64.255B 73.00
Vertex Pharmaceuticals (VRTX) United States $48.168B 18.72
Biogen (BIIB) United States $44.485B 12.21
BeiGene (BGNE) Cayman Islands $37.075B 0.00
Seagen (SGEN) United States $28.939B 48.79
Genmab (GNMSF) Denmark $28.431B 71.07
Genmab (GMAB) Denmark $28.203B 69.26
Horizon Therapeutics Public (HZNP) Ireland $24.401B 23.13
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $21.804B 0.00
Bio-Techne Corp (TECH) United States $20.666B 92.94
Exact Sciences (EXAS) United States $18.080B 0.00
Novavax (NVAX) United States $16.902B 0.00
Repligen (RGEN) United States $16.804B 128.05
Incyte (INCY) United States $16.764B 39.74
ARGENX SE-ADR (ARGX) Netherlands $16.101B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.188B 101.82
Guardant Health (GH) United States $13.084B 0.00
QIAGEN (QGEN) Netherlands $12.471B 21.12
Zai Lab (ZLAB) China $11.835B 0.00
Intellia Therapeutics (NTLA) United States $10.903B 0.00
CureVac (CVAC) Germany $9.962B 0.00
Mirati Therapeutics (MRTX) United States $9.161B 0.00
Ascendis Pharma (ASND) Denmark $8.889B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.875B 22.79
Biohaven Pharmaceutical Holding (BHVN) United States $8.670B 0.00
Acceleron Pharma (XLRN) United States $8.499B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Sarepta Therapeutics (SRPT) United States $6.840B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.542B 0.00
Vir Biotechnology (VIR) United States $6.491B 0.00
Fate Therapeutics (FATE) United States $6.396B 0.00
Legend Biotech (LEGN) United States $6.392B 0.00
Beam Therapeutics (BEAM) United States $6.324B 0.00
Exelixis (EXEL) United States $6.244B 68.35
Blueprint Medicines (BPMC) United States $6.161B 17.39
Denali Therapeutics (DNLI) United States $6.065B 171.93
Halozyme Therapeutics (HALO) United States $5.868B 23.97
NeoGenomics (NEO) United States $5.780B 783.33
AbCellera Biologics (ABCL) $5.755B 0.00
Twist Bioscience (TWST) United States $5.621B 0.00
I-Mab (IMAB) China $5.566B 0.00
Certara (CERT) United States $5.415B 0.00
Adaptive Biotechnologies (ADPT) United States $5.308B 0.00
Alkermes (ALKS) Ireland $4.779B 141.05
Arvinas (ARVN) United States $4.540B 0.00
Editas Medicine (EDIT) United States $3.973B 0.00
Reata Pharmaceuticals (RETA) United States $3.885B 0.00
Arena Pharmaceuticals (ARNA) United States $3.656B 0.00
Galapagos (GLPG) Belgium $3.593B 0.00
SpringWorks Therapeutics (SWTX) United States $3.500B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.484B 0.00
Prothena (PRTA) Ireland $3.305B 0.00
Kymera Therapeutics (KYMR) United States $3.087B 0.00
Emergent Biosolutions (EBS) United States $3.027B 7.30
Insmed (INSM) United States $2.998B 0.00
ALX Oncology Holdings (ALXO) United States $2.997B 0.00
Amicus Therapeutics (FOLD) United States $2.927B 0.00
Apellis Pharmaceuticals (APLS) United States $2.876B 0.00
Intra-Cellular Therapies (ITCI) United States $2.871B 0.00
Cytokinetics (CYTK) United States $2.708B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.684B 0.00
Heska (HSKA) United States $2.647B 507.49
Instil Bio (TIL) United States $2.616B 0.00
Myriad Genetics (MYGN) United States $2.596B 0.00
Arcus Biosciences (RCUS) United States $2.507B 0.00
Atea Pharmaceuticals (AVIR) United States $2.396B 0.00
Celldex Therapeutics (CLDX) United States $2.378B 0.00
Sorrento Therapeutics (SRNE) United States $2.376B 0.00
C4 Therapeutics (CCCC) United States $2.358B 0.00
Morphic Holding (MORF) United States $2.329B 0.00
Ligand Pharmaceuticals (LGND) United States $2.280B 33.34
Vericel (VCEL) United States $2.238B 266.67
Seer (SEER) $2.200B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.125B 36.19
Alector (ALEC) United States $2.084B 0.00
Myovant Sciences (MYOV) United Kingdom $2.036B 0.00
Amarin (AMRN) Ireland $2.008B 508.00
Revance Therapeutics (RVNC) United States $1.977B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.946B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.870B 0.00
REGENXBIO (RGNX) United States $1.857B 0.00
Castle Biosciences (CSTL) United States $1.855B 0.00
NGM Biopharmaceuticals (NGM) United States $1.722B 0.00
Dynavax Technologies (DVAX) United States $1.718B 0.00
MorphoSys AG (MOR) Germany $1.712B 0.00
Berkeley Lights (BLI) United States $1.701B 0.00
Global Blood Therapeutics (GBT) United States $1.691B 0.00
UniQure (QURE) Netherlands $1.687B 5.74
PHARMA MAR SA (PHMMF) Spain $1.677B 0.00
Inovio Pharmaceuticals (INO) United States $1.639B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.618B 0.00
Codexis (CDXS) United States $1.606B 0.00
Zymeworks (ZYME) Canada $1.534B 0.00
PureTech Health (PRTC) United States $1.516B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.515B 0.00
Kadmon Holdings (KDMN) United States $1.510B 0.00
Ocugen (OCGN) United States $1.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.477B 0.00
Bionano Genomics (BNGO) United States $1.443B 0.00
Nurix Therapeutics (NRIX) United States $1.424B 0.00
Zealand Pharma (ZEAL) Denmark $1.393B 0.00
MaxCyte (MXCT) United States $1.377B 0.00
Agenus (AGEN) United States $1.357B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.356B 0.00
Inhibrx (INBX) United States $1.350B 0.00
Sangamo Therapeutics (SGMO) United States $1.349B 0.00
Travere Therapeutics (TVTX) United States $1.348B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.332B 0.00
Coherus BioSciences (CHRS) United States $1.330B 0.00
Genetron Holdings (GTH) China $1.296B 0.00
Fulcrum Therapeutics (FULC) United States $1.248B 0.00
Avid Bioservices (CDMO) United States $1.232B 251.00
Bluebird Bio (BLUE) United States $1.214B 0.00
Scholar Rock Holding (SRRK) United States $1.175B 0.00
Northwest Biotherapeutics (NWBO) United States $1.130B 0.00
Precigen (PGEN) United States $1.124B 0.00
MannKind (MNKD) United States $1.118B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.104B 0.00
BioAtla (BCAB) United States $1.091B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.072B 0.00
RAPT THERAPTICS (RAPT) United States $1.059B 0.00
ImmunityBio (IBRX) United States $1.054B 0.00
Repare Therapeutics (RPTX) Canada $1.051B 0.00
Absci (ABSI) United States $1.015B 0.00
IDEAYA Biosciences (IDYA) United States $1.008B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Nkarta (NKTX) United States $0.988B 0.00
Prometheus Biosciences (RXDX) United States $0.960B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.917B 28.43
Syndax Pharmaceuticals (SNDX) United States $0.914B 0.00
Avidity Biosciences (RNA) United States $0.895B 0.00
Merus (MRUS) Netherlands $0.887B 0.00
Sutro Biopharma (STRO) United States $0.884B 0.00
Immatics (IMTX) Germany $0.856B 0.00
VBI Vaccines (VBIV) United States $0.806B 0.00
Shattuck Labs (STTK) United States $0.800B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.793B 0.00
Cara Therapeutics (CARA) United States $0.767B 95.69
Mesoblast (MESO) Australia $0.762B 0.00
Amryt Pharma (AMYT) United Kingdom $0.744B 0.00
Precision BioSciences (DTIL) United States $0.739B 0.00
Curis (CRIS) United States $0.730B 0.00
AnaptysBio (ANAB) United States $0.729B 0.00
Akoya Biosciences (AKYA) United States $0.716B 0.00
Keros Therapeutics (KROS) United States $0.683B 0.00
Mersana Therapeutics (MRSN) United States $0.680B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.676B 12.32
Xenon Pharmaceuticals (XENE) Canada $0.668B 0.00
MiMedx (MDXG) United States $0.657B 0.00
Pliant Therapeutics (PLRX) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Adagene (ADAG) China $0.641B 0.00
G1 THERAPEUTICS (GTHX) United States $0.639B 0.00
Innate Pharma S.A (IPHA) France $0.637B 0.00
Affimed (AFMD) Germany $0.619B 0.00
Seres Therapeutics (MCRB) United States $0.618B 0.00
Protagonist Therapeutics (PTGX) United States $0.616B 0.00
Cellectis S.A (CLLS) France $0.614B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Spero Therapeutics (SPRO) United States $0.611B 0.00
Pharming Group (PHAR) Netherlands $0.609B 0.00
BeyondSpring (BYSI) United States $0.601B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.597B 0.00
ALBIREO PHARMA (ALBO) United States $0.585B 0.00
Gritstone Bio (GRTS) United States $0.584B 0.00
MeiraGTx Holdings (MGTX) United States $0.571B 0.00
Epizyme (EPZM) United States $0.561B 0.00
DBV Technologies S.A (DBVT) France $0.558B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.557B 0.00
Clovis Oncology (CLVS) United States $0.541B 0.00
Inventiva S.A (IVA) France $0.541B 0.00
VistaGen Therapeutics (VTGN) United States $0.540B 0.00
Vaccitech (VACC) United Kingdom $0.537B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
Bolt Biotherapeutics (BOLT) United States $0.519B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.515B 0.00
Verastem (VSTM) United States $0.508B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.504B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.488B 0.00
Selecta Biosciences (SELB) United States $0.480B 0.00
Cel-Sci (CVM) United States $0.480B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.465B 0.00
XBiotech (XBIT) United States $0.459B 0.00
Clene (CLNN) United States $0.457B 0.00
Bellus Health (BLU) Canada $0.454B 0.00
ChromaDex (CDXC) United States $0.443B 0.00
Geron (GERN) United States $0.436B 0.00
Compugen (CGEN) Israel $0.426B 0.00
Codiak BioSciences (CDAK) United States $0.426B 0.00
Arbutus Biopharma (ABUS) United States $0.425B 0.00
Cue Biopharma (CUE) United States $0.417B 0.00
SQZ Biotechnologies (SQZ) United States $0.405B 0.00
Oncobiologics (OTLK) United States $0.398B 0.00
Starpharma Holdings (SPHRY) Australia $0.397B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.394B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.392B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 11.79
Clearside Biomedical (CLSD) United States $0.378B 0.00
ANI Pharmaceuticals (ANIP) United States $0.374B 10.21
Aeglea BioTherapeutics (AGLE) United States $0.373B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.372B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.366B 0.00
Athenex (ATNX) United States $0.365B 0.00
Cogent Biosciences (COGT) United States $0.351B 0.00
Cybin (CYBN) Canada $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.338B 0.00
Theratechnologies (THTX) Canada $0.333B 0.00
Opthea (OPT) Australia $0.332B 0.00
Neoleukin Therapeutics (NLTX) United States $0.330B 0.00
Fortress Biotech (FBIO) United States $0.319B 0.00
Athersys (ATHX) United States $0.314B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.313B 0.00
Prima BioMed (IMMP) Australia $0.310B 0.00
Syros Pharmaceuticals (SYRS) United States $0.308B 0.00
INmune Bio (INMB) United States $0.307B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.305B 0.00
Angion Biomedica (ANGN) United States $0.294B 0.00
AquaBounty Technologies (AQB) United States $0.286B 0.00
WAVE Life Sciences (WVE) Singapore $0.284B 0.00
Beyond Air (XAIR) United States $0.281B 0.00
Puma Biotechnology (PBYI) United States $0.271B 0.00
XOMA (XOMA) United States $0.270B 113.71
Checkpoint Therapeutics (CKPT) United States $0.263B 0.00
Cardiff Oncology (CRDF) United States $0.261B 0.00
Frequency Therapeutics (FREQ) United States $0.249B 0.00
IBio (IBIO) United States $0.248B 0.00
Kaleido Biosciences (KLDO) $0.240B 0.00
Kamada (KMDA) Israel $0.236B 19.63
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
OVID THERAPEUTC (OVID) United States $0.227B 1.99
AVEO Pharmaceuticals (AVEO) United States $0.227B 0.00
Adverum Biotechnologies (ADVM) United States $0.220B 0.00
Adicet Bio (ACET) United States $0.219B 0.00
Trevena (TRVN) United States $0.206B 0.00
Kala Pharmaceuticals (KALA) United States $0.196B 0.00
Seelos Therapeutics (SEEL) United States $0.194B 0.00
Synlogic (SYBX) United States $0.194B 0.00
NextCure (NXTC) United States $0.190B 0.00
OSMOTICA PHARM (OSMT) United States $0.187B 0.00
TELA Bio (TELA) United States $0.184B 0.00
Talis Biomedical (TLIS) United States $0.183B 0.00
ObsEva SA (OBSV) Switzerland $0.178B 0.00
Erytech Pharma SA (ERYP) France $0.177B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
ATyr Pharma (LIFE) United States $0.173B 0.00
CorMedix Inc (CRMD) United States $0.171B 0.00
HOOKIPA Pharma (HOOK) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.168B 49.43
ADMA Biologics Inc (ADMA) United States $0.166B 0.00
Leap Therapeutics (LPTX) United States $0.165B 0.00
VolitionRX (VNRX) United States $0.164B 0.00
SESEN BIO, INC (SESN) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Aptinyx (APTX) United States $0.160B 0.00
Edesa Biotech (EDSA) Canada $0.158B 0.00
Galena Biopharma (SLS) United States $0.155B 0.00
Catalyst Biosciences (CBIO) United States $0.154B 0.00
Biofrontera AG (BFRA) Germany $0.153B 0.00
Dyadic (DYAI) United States $0.152B 0.00
TScan Therapeutics (TCRX) United States $0.150B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.149B 0.00
LogicBio Therapeutics (LOGC) United States $0.143B 0.00
VTv Therapeutics (VTVT) United States $0.142B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.140B 0.00
Vascular Biogenics (VBLT) Israel $0.140B 0.00
Novogen (KZIA) Australia $0.138B 0.00
Strongbridge Biopharma (SBBP) United States $0.135B 0.00
Cyclerion Therapeutics (CYCN) United States $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.131B 0.00
X4 Pharmaceuticals (XFOR) United States $0.127B 0.00
Purple Biotech (PPBT) Israel $0.123B 0.00
Abeona Therapeutics (ABEO) United States $0.122B 0.00
Evofem Biosciences (EVFM) United States $0.121B 0.00
Orgenesis (ORGS) United States $0.121B 246.00
Eton Pharmaceuticals (ETON) United States $0.120B 0.00
Exicure (XCUR) United States $0.117B 0.00
Eyenovia (EYEN) United States $0.115B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Voyager Therapeutics (VYGR) United States $0.113B 6.46
Entera Bio (ENTX) Israel $0.110B 0.00
Yumanity Therapeutics (YMTX) United States $0.109B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Palatin Technologies (PTN) United States $0.103B 0.00
Viridian Therapeutics (VRDN) United States $0.102B 0.00
Cocrystal Pharma (COCP) United States $0.099B 0.00
Armata Pharmaceuticals (ARMP) United States $0.093B 0.00
Aadi Bioscience (AADI) United States $0.092B 0.00
Pluristem Therapeutics (PSTI) Israel $0.092B 0.00
Celsion (CLSN) United States $0.088B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
Lumos Pharma (LUMO) United States $0.083B 0.00
Adocia (ADOCY) France $0.083B 0.00
Aptevo Therapeutics (APVO) United States $0.082B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.076B 0.00
Aytu BioPharma (AYTU) United States $0.076B 0.00
Liminal BioSciences (LMNL) Canada $0.075B 0.00
Statera Biopharma (STAB) United States $0.075B 0.00
TRACON Pharmaceuticals (TCON) United States $0.073B 0.00
Evogene (EVGN) Israel $0.073B 0.00
AEterna Zentaris (AEZS) United States $0.072B 0.00
DiaMedica Therapeutics (DMAC) United States $0.072B 0.00
Advaxis (ADXS) United States $0.070B 0.00
Vaccinex (VCNX) United States $0.067B 0.00
Celyad SA (CYAD) Belgium $0.067B 0.00
Longeveron (LGVN) United States $0.067B 0.00
AIkido Pharma (AIKI) United States $0.066B 0.00
Vyant Bio (VYNT) United States $0.066B 0.00
ABVC BioPharma (ABVC) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Enveric Biosciences (ENVB) United States $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.053B 0.00
Windtree Therapeutics (WINT) United States $0.051B 0.00
Antibe Therapeutics (ATBPF) Canada $0.051B 0.00
BioCardia (BCDA) United States $0.051B 0.00
Genetic Technologies (GENE) Australia $0.049B 0.00
Acorda Therapeutics (ACOR) United States $0.049B 1.01
Cyclacel Pharmaceuticals (CYCC) United States $0.048B 0.00
Forte Biosciences (FBRX) United States $0.047B 0.00
ARIDIS PHARMACT (ARDS) United States $0.046B 0.00
Vallon Pharmaceuticals (VLON) United States $0.045B 0.00
ZIVO Bioscience (ZIVO) United States $0.043B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Soligenix (SNGX) United States $0.041B 0.00
Cyclo Therapeutics (CYTH) United States $0.040B 0.00
Invo BioScience (INVO) United States $0.035B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.034B 0.00
Palisade Bio (PALI) United States $0.033B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.029B 0.00
Happiness Biotech Group (HAPP) China $0.029B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
ThermoGenesis Holdings (THMO) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.015B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00